Month: April 2020

PRESS RELEASE: REGULATED INFORMATION20 April 2020, 07:00 CEST                                                                                                           Important Notice Regarding the Annual and Extraordinary Shareholders’ MeetingsMechelen, Belgium, 20 April 2020 – On 7 April 2020, Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), published its convening notice for the annual and extraordinary shareholders’ meetings of the Company that will be held on 8 May 2020. On 9 April 2020, the Belgian Royal Decree no. 4 containing various provisions regarding co-ownership and the law on companies and associations in the framework of the fight against the Covid-19 pandemic was published.Using the possibility offered by the aforementioned Royal Decree no. 4, and...

PERSBERICHT: GEREGLEMENTEERDE INFORMATIE 20 april 2020, 07:00 CEST                                                           Belangrijke Mededeling Inzake Gewone en Buitengewone Algemene Aandeelhoudersvergaderingen Mechelen, België, 20 april 2020 – Op 7 april 2020 publiceerde Biocartis Group NV (de ‘Vennootschap’ of ‘Biocartis’), een innovatief bedrijf in de moleculaire diagnostiek (Euronext Brussels: BCART), haar oproeping tot de gewone en buitengewone algemene aandeelhoudersvergaderingen van de Vennootschap die gehouden zullen worden op vrijdag 8 mei 2020. Op 9 april 2020 werd het Koninklijk Besluit nr. 4 houdende diverse bepalingen inzake mede-eigendom en het vennootschaps- en verenigingsrecht in het kader van de strijd tegen de Covid-19 pandemie gepubliceerd.Gebruik makend van de mogelijkheid geboden door het voormelde Koninklijk Besluit...

Technology has potential to reimagine treatment for amblyopia (“lazy eye”), a leading cause of vision loss in children and young adults1Acquisition expands the Novartis refractive disorder pipeline in ophthalmologyNovartis will work with Ubisoft and McGill University to accelerate product development to enable faster uptake for patients—PoC studies planned later in 2020 Basel, April 20, 2020 — Novartis announced today that it has completed the acquisition of Amblyotech, a US-based software startup, and will, in collaboration with Ubisoft and McGill University, pursue the development of the acquired digital technology for the treatment of amblyopia.It is estimated that amblyopia affects roughly 3% of the global population, some of whom could be appropriate candidates for this therapy if approved1. The condition can lead to poor vision and...

Harvest volumes Q1 2020 (1)In connection with the presentation of the Q4 2019 results, Mowi ASA guided a total harvest volume of 84 thousand tonnes (GWE) for Q1 2020.Note: (1) The harvest volumes are provided in gutted weight equivalents (GWE). The figures include salmonid species only.Additional informationOperational EBIT for the Group was approximately EUR 107 million in Q1 2020 (EUR 196 million in Q1 2019), of which Farming EUR 101 million, Sales & Marketing EUR 14 million and Feed EUR -1 million.Total Operational EBIT per kg through the value chain was approximately as follows:The contract share was 43% in Norway and 75% in Scotland in the quarter. Blended cost in the first quarter was 0.22 EUR/kg higher than in the fourth quarter of 2019 on 29% lower volumes.Reported financial net interest-bearing debt (NIBD) was approximately...

SANTA ANA, Calif., April 19, 2020 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”) today announced the completion of the divestiture of its four China manufacturing plants comprising substantially all of the assets of its Mobility business unit.  The Buyer is AKMMeadville Electronics (Xiamen) Co., Ltd. (“AKMMeadville”), a Chinese consortium consisting of Meizhi Investment (Xiamen) Co., Ltd., Xiamen Semiconductor Investment Group Co., Ltd., AKM Electronics Industrial (Panyu) Ltd. (“AKM”), and Anmei Ventures (Xiamen) Equity Investment Partnership (Limited Partnership) (“Anmei”).The transaction is an important step in advancing TTM’s stated strategy of increasing its focus on growth markets characterized by long product cycles such as aerospace and defense, automotive, medical, industrial, instrumentation and networking/communications...

– PaTH Forward Trial met key objectives and showed that TransCon PTH eliminated standard of care in 82 percent of subjects within four weeks –– Conference call today at 6 p.m. Eastern Time to review data –COPENHAGEN, Denmark, April 19, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced positive top-line results from the four-week fixed dose, blinded portion of PaTH Forward, a global phase 2 trial evaluating the safety, tolerability and efficacy of TransCon PTH in adult subjects with hypoparathyroidism (HP).TransCon PTH is an investigational long-acting prodrug of parathyroid hormone (PTH) in development as a once-daily replacement therapy for adult hypoparathyroidism designed to replace PTH at physiologic...

Kvika has signed an agreement to sell all its shares in Korta hf. to the UK based fintech company Rapyd. Other shareholders of Korta are also parties to the agreement. The sale is subject to the approval of the Financial Supervision of the Central Bank of Iceland.The purchase price will be paid in cash. Part of the payment is based on Korta’s operations this year and the full price will, thus, not be known until early next year. Kvika currently estimates that the purchase price for the bank’s shares will be equivalent to its book value at the end of last year and will therefore not have an impact on this year’s earnings.Marinó Örn Tryggvason, Kvika’s CEO: “It is a pleasure to announce the sale of Korta which Kvika, along with a group of investors, refinanced in the year 2017 after a shock Korta suffered due to the...

Kvika hefur undirritað samning um sölu á öllum eignarhlut sínum í Korta hf. til breska fjártæknifélagsins Rapyd. Aðrir hluthafar Korta eru einnig aðilar að samningnum. Samningurinn er gerður með fyrirvara um samþykki Fjármálaeftirlits Seðlabanka Íslands.Kaupverðið greiðist með reiðufé. Hluti kaupverðs tekur mið af rekstri Korta á þessu ári og því liggur ekki fyrir hvert endanlegt kaupverð verður fyrr en í upphafi næsta árs. Núverandi mat bankans á kaupverði fyrir eignarhlut bankans í Korta er að það verði í samræmi við bókfært virði hlutarins um sl. áramót og hafi því ekki áhrif á afkomu bankans á þessu rekstrarári.Marinó Örn Tryggvason, forstjóri Kviku: „Það er gaman að geta tilkynnt um sölu Korta hf. sem bankinn, ásamt hópi fjárfesta, endurfjármagnaði árið 2017 í kjölfar reiðarslags sem félagið varð fyrir vegna gjaldþrots Monarch flugfélagsins....

CBs are convertible at HK$1.215 per share, or approx. 5.6% of GOME shareholdingPDD will bring GOME’s entire product range onto the e-commerce platform and help with its digitization strategySHANGHAI, China, April 19, 2020 (GLOBE NEWSWIRE) — Pinduoduo Inc. (“PDD”, or the “Company) (NASDAQ: PDD),  an innovative and fast growing technology platform and one of the leading Chinese e-commerce players, today announced it will subscribe to US$200 million in convertible bonds (“CBs”) issued by household appliance and electronics retailer GOME Retail Holdings Limited (“GOME”) (HKEX stock code: 493.HK) as part of a strategic partnership to bring more value-for-money merchandise to the Company’s 585.2 million users.“This strategic partnership is a win-win-win,” said Mr. David Liu, Vice President of Strategy at PDD. “Consumers win because they...

 Impacts of the COVID-19 crisis: Q1 2020 revenue down by -7.9% on a reported basisVery strong growth in e-commerce, in all countries, during the lockdown periodImplementation of a €500 million Term Loan facility guaranteed by the French State to secure cash flow and prepare activities recoveryQ1 2020 revenue of €1,490 million, down -7.9% on a reported basis and -10.3% on a like-for-like basisClosure of almost all of the Group’s physical stores from mid-March onwards, leading to a drop in Group sales of around 30% in MarchGrowth of cumulative revenue in January/February of +2.8% on a reported basis and stable on a like-for-like basis, in a consumer environment marked by continuing strikes in France and a shorter promotional sales periodExcellent operational execution on digital platforms that allow the Group to absorb a doubling...